Gilbert H Tang, MD Email Gilbert Tang
- ASSOCIATE PROFESSOR | Cardiovascular Surgery
- Cardiovascular Surgery
- Chinese (Cantonese)
- Chinese (Mandarin)
- Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside and Mount Sinai West
- The Mount Sinai Hospital
- Cardiovascular Surgery 212-659-9472 212-659-9472
Dr. Gilbert Tang is currently the Surgical Director of the Structural Heart Program at the Mount Sinai Health System. He has performed over 1000 cases of transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (MitraClip) procedures with excellent outcomes, on par with some of the top programs in the country. Dr. Tang has achieved many “first” successes in the region and United States, including transcatheter mitral and tricuspid valve replacement and tricuspid valve repair with MitraClip, all performed via the groin without open surgery. Prior to Mount Sinai, Dr. Tang was the Director of the Valve Disease Center at Westchester Medical Center, playing a pivotal role in the launch of their Transcatheter Heart Program. His “concierge” model of care has been well received and recognized in the New York area.
As a regularly invited faculty and guest lecturer at national and international conferences, Dr. Tang is leading a number of cutting-edge research projects in TAVR and transcatheter mitral and tricuspid valve therapies. He pioneered a technique to help better orient a transcatheter heart valve during TAVR to make it easier to reaccess the coronary arteries. His research and clinical results have been published in many top peer-reviewed medical journals and presented at many international conferences. He has trained many physicians and heart teams to perform transcatheter valve procedures around the world. He is currently involved in several multicenter studies with leading institutions in the US and globally.
Dr. Tang received his bachelor's degree at Harvard University and MD at the University of Toronto, where he completed his residency in cardiac surgery as the Chief Resident at the Toronto General Hospital. He completed a Master of Science in tissue engineering at the University of Toronto and an MBA at the Harvard Business School. Dr. Tang pursued specialized training at Mount Sinai Medical Center in New York focusing on complex mitral valve repair and TAVR. He also underwent advanced training in TAVR at the Leipzig Heart Center in Germany and the University of Pennsylvania. Dr. Tang is a Diplomat and Fellow of the Royal College of Physicians and Surgeons of Canada.
TCTMD: Dedicated Structural Heart Training Pathway in the Works for Surgeons 2/4/20 By Yael L. Maxwell
To TCTMD, panelist and surgeon Gilbert Tang, MD (Mount Sinai Health System, New York, NY), said he has been part of the ABTS steering committee with Fullerton. “We really strongly believe that surgical trainees who are interested in valvular heart disease should equip themselves with the skill set and knowledge to treat patients with all modalities possible, including medicaltherapy,” he said. “But not to have that knowledge and skill set to be able to do that presents an inherent bias, just like cardiologists. That's where the heart team comes in.”
TCTMD: MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR 1/24/20 By Shelley Wood
Gilbert Tang, MD (Mount Sinai Health System, New York, NY), has previously highlighted the fact that quantitative echocardiography in MR is dynamic, making it all the more challenging for referring centers to decide whether a given patient is a suitable candidate.
The New York Times: Bernie Sanders Had Heart Attack, His Doctors Say as He Leaves Hospital 10/4/19 By Sydney Ember
A heart attack means that a portion of the heart muscle died, starved of blood when a vessel was blocked, Dr. Gilbert Tang, a heart surgeon at Mount Sinai Hospital in New York, said.
“The first question is, how serious was the heart attack? What muscle was damaged and how will that affect the heart’s function?” Dr. Tang said. “If it was a significant portion of the heart, will that affect the heart’s ability to pump?”
If only a small portion of heart muscle was damaged, he added, Mr. Sanders should make a full recovery — even at 78. These days recovery does not depend on age so much as other medical issues, like lung problems, he said.
That does not mean that Mr. Sanders can simply continue as if nothing happened, though. Doctors usually recommend a cardiac rehabilitation program, which is essentially an exercise program in which patients are closely monitored. Such a program, Dr. Tang said, “conditions the heart to work harder.”
Mr. Sanders would normally also take a cocktail of drugs to reduce his risk of another heart attack, including powerful anti-clotting medications that require close monitoring for a month, Dr. Tang said.
The New York Times: Bernie Sanders Is Hospitalized, Raising Questions About His Candidacy 10/2/19 By Sydney Ember and Jonathan Martin
Dr. Gilbert Tang, a heart surgeon at the Mount Sinai Hospital in New York, said that if Mr. Sanders’s heart was not damaged, he should make a full recovery. But he also sounded a note of caution, saying the risks depended on which artery was blocked: “We don’t know what the anatomy looks like and what kind of stent at what location,” he said.
"The issue is that, unlike surgery where we actually remove the leaflets of the aortic valve and put the new valve in and then align the commissures properly, in TAVR nobody has been paying attention to how the valve aligns wiht the native anatomy," lead investigator Gilbert Tang, MD told TCTMD.
Health.com: Mick Jagger Had a Heart Valve Replacement -- Here's What That Means 4/5/19
"People need this procedure because they have aortic stenosis--the stiffening and narrowing of one of the heart valves," says Gilbert Tang, MD, surgical director of the Structural Heart Program at the Mount Sinai Health System in New York City.
The New York Times: Tens of Thousands of Heart Patients May Not Need Open-Heart Surgery 3/16/19
“If I were a patient, I would choose TAVR,” said Dr. Gilbert Tang, a heart surgeon at the Icahn School of Medicine at Mount Sinai in New York, who was not involved in the new research.
The New York Times: Tiny Device Is a “Huge Advance” for Treatment of Severe Heart Failure, 9/23/18
The results have left leading researchers unexpectedly optimistic. The trial sends “a very, very powerful message,” said Dr. Gilbert Tang, a heart surgeon at Mount Sinai Medical Center, which enrolled a patient in the trial.
Not so fast, said Gilbert Tang, MD (Mount Sinai Health System/Icahn School of Medicine, New York, NY), who took the stage after Feldman. Or at least, “not yet.”
Percutaneous procedures, at least for now, do not offer the variety of approaches that surgery can offer, he argued, pointing out that MR comes in myriad forms. Different MR etiology, mitral lesions, and patient risk profile all play an important role. And while transcatheter therapies have evolved to approximate edge-to-edge, annuloplasty, and chordal replacement procedures, no percutaneous therapy is able to perform resection and reconstruction, a common surgical technique, Tang said.
- Aortic Aneurysm
- Aortic Insufficiency
- Aortic Regurgitation
- Aortic Stenosis
- Aortic Valve Disease
- Atrial Fibrillation
- Bypass Surgery Consultation - CABG
- Cardiac Catheterization
- Cardiothoracic Surgery Consultation
- Coronary Artery Disease
- Heart Failure
- Heart Murmur
- Leaky Heart Valve
- Minimally Invasive Bypass Consultation - OPCAB
- Mitral Regurgitation
- Mitral Stenosis
- Mitral Valve Disease
- Pericardial Cyst / Mass
- Pleural Effusion
- Pulmonary Valve Disease
- Thoracic Aortic Aneurysm
- Traumatic Aortic Disruption
- Tricuspid Valve Disease
- Valvular Heart Disease
BA, Harvard University
MD, University of Toronto
MBA, Harvard Business School
MSc, University of Toronto
Residency, Cardiac Surgery
University of Toronto
English, Chinese (Cantonese), Chinese (Mandarin)
New York Society for Thoracic Surgery (NYSTS)
American Association for Thoracic Surgery (AATS)
New York Society for Thoracic Surgery
Transcatheter heart valve, valvular heart disease
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Tang during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Abbott Laboratories
- W. L. Gore & Associates, Inc.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Abbott Laboratories
- Edwards Lifesciences
- Medtronic, Inc.
Scientific Advisory Board:
- Abbott Laboratories
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.